Name
Weight
2.82 %
2.75 %
2.63 %
2.59 %
2.45 %
2.45 %
2.36 %
2.36 %
2.34 %
2.30 %
2.23 %
2.21 %
2.15 %
2.12 %
2.08 %
2.01 %
1.97 %
1.96 %
1.85 %
1.81 %
1.63 %
1.63 %
1.47 %
1.45 %
1.44 %
1.40 %
1.38 %
1.35 %
1.34 %
1.31 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Analysis
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Name
Weight
2.82 %
2.75 %
2.63 %
2.59 %
2.45 %
2.45 %
2.36 %
2.36 %
2.34 %
2.30 %
2.23 %
2.21 %
2.15 %
2.12 %
2.08 %
2.01 %
1.97 %
1.96 %
1.85 %
1.81 %
1.63 %
1.63 %
1.47 %
1.45 %
1.44 %
1.40 %
1.38 %
1.35 %
1.34 %
1.31 %
Analyst ratings
FAQ
- What is XBI?
- Does XBI pay dividends?
- What stocks are in XBI?
- What is the current assets under management for XBI?
- What is XBI average volume?
- What is XBI expense ratio?
- What is XBI inception date?
What is XBI?
The XBI ETF, or SPDR S&P Biotech ETF, focuses on the biotechnology sector. It tracks the performance of biotech companies in the S&P Total Market Index, offering investors exposure to innovative healthcare solutions and potential growth in the biotech industry.
Does XBI pay dividends?
Yes, the SPDR S&P Biotech ETF does pays dividends, with
the most recent payment being
$0.00
per share. The last ex-dividend date was on December 23, 2024, and the next ex-dividend date has not been announced yet
What stocks are in XBI?
As of today, SPDR S&P Biotech ETF inlcudes 143 holdings, with 137 of them being companies from 4 different countries and 1 sectors. The most weighted holdings are Gilead Sciences (2.82%), AbbVie (2.75%) and Amgen (2.63%)
What is the current assets under management for XBI?
Assets under management of SPDR S&P Biotech ETF is $7 B
What is XBI average volume?
Average volume of SPDR S&P Biotech ETF is $8 M
What is XBI expense ratio?
Expense ratio of SPDR S&P Biotech ETF is 0.35%
What is XBI inception date?
Inception date of SPDR S&P Biotech ETF is January 31, 2006